These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 3791477)

  • 21. Ceftazidime and cefotaxime--the clinician's choice.
    Puthucheary SD; Goldsworthy PJ
    Clin Ther; 1989; 11(2):186-204. PubMed ID: 2660995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)].
    Nasnas R; Gutmann L; Kitzis MD; Goldstein F; Acar JF
    Pathol Biol (Paris); 1982 Jun; 30(6):341-4. PubMed ID: 6287385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Review of oral cephalosporins. Basis for a rational choice].
    Forti IN
    Medicina (B Aires); 1994; 54(5 Pt 1):439-58. PubMed ID: 7658980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of ceftazidime and ceftriaxone.
    Keenholtz SL; Jacobus NV; Tally FP; Gorbach SL
    Clin Ther; 1983; 5(6):603-16. PubMed ID: 6313195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serious pediatric infections.
    Kaplan SL
    Am J Med; 1990 Apr; 88(4A):18S-24S. PubMed ID: 2183605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment.
    Kanegaye JT; Soliemanzadeh P; Bradley JS
    Pediatrics; 2001 Nov; 108(5):1169-74. PubMed ID: 11694698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity, pharmacokinetics, clinical efficacy, safety and pharmacoeconomics of ceftriaxone compared with third and fourth generation cephalosporins: review.
    Bijie H; Kulpradist S; Manalaysay M; Soebandrio A
    J Chemother; 2005 Feb; 17(1):3-24. PubMed ID: 15828439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bactericidal action of chloramphenicol and synergism with beta-lactam antibiotics].
    Guggenbichler JP
    Padiatr Padol; 1983; 18(1):11-20. PubMed ID: 6403908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacterial meningitis in adults.
    Wispelwey B; Tunkel AR; Scheld WM
    Infect Dis Clin North Am; 1990 Dec; 4(4):645-59. PubMed ID: 2277193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Haemophilus influenzae, the second cause of bacterial meningitis in children in Madagascar].
    Razafindralambo M; Ravelomanana N; Randriamiharisoa FA; Migliani R; Clouzeau J; Raobijaona H; Rasamoelisoa J; Pfister P
    Bull Soc Pathol Exot; 2004 May; 97(2):100-3. PubMed ID: 15255350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial meningitis in neonates and children.
    Sáez-Llorens X; McCracken GH
    Infect Dis Clin North Am; 1990 Dec; 4(4):623-44. PubMed ID: 2277192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended-spectrum (second- and third-generation) cephalosporins.
    Eriksen NL; Blanco JD
    Obstet Gynecol Clin North Am; 1992 Sep; 19(3):461-74. PubMed ID: 1436924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacterial meningitis: is there a "best" antimicrobial therapy?
    Eichenwald HF
    Eur J Pediatr; 1987 May; 146(3):216-20. PubMed ID: 3297707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Third generation cephalosporins versus conventional antibiotics for treating acute bacterial meningitis.
    Prasad K; Kumar A; Gupta PK; Singhal T
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD001832. PubMed ID: 17943757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penetration of newer cephalosporins into cerebrospinal fluid.
    Cherubin CE; Eng RH; Norrby R; Modai J; Humbert G; Overturf G
    Rev Infect Dis; 1989; 11(4):526-48. PubMed ID: 2672238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacterial meningitis. Rational selection and use of antibacterial drugs.
    Whitby M; Finch R
    Drugs; 1986 Mar; 31(3):266-78. PubMed ID: 3519175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of gram-negative bacillary meningitis: role of the new cephalosporin antibiotics.
    Cherubin CE; Corrado ML; Nair SR; Gombert ME; Landesman S; Humbert G
    Rev Infect Dis; 1982; 4 Suppl():S453-64. PubMed ID: 6294799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful moxalactam therapy for gram-negative bacillary meningitis in neonates.
    Ramos OM; Kaplan SL; Mason EO; Denson S; Pickering LK
    South Med J; 1982 May; 75(5):632-3. PubMed ID: 6210970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Moxalactam penetration into cerebrospinal fluid in patients with bacterial meningitis.
    Modai J; Wolff M; Lebas J; Meulemans A; Manuel C
    Antimicrob Agents Chemother; 1982 Apr; 21(4):551-3. PubMed ID: 6211136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.